Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMainz Biomed B.V. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$2.80 | -$2.80 | -$2.80 |
| Q2 2025 | 1 | -$2.40 | -$2.40 | -$2.40 |
| Q3 2025 | 1 | -$2.00 | -$2.00 | -$2.00 |
| Q4 2025 | 1 | -$2.00 | -$2.00 | -$2.00 |
| Q1 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2026 | 0 | $0.00 | $0.00 | $0.00 |
Mainz Biomed B.V. Earnings Date And Information
Mainz Biomed B.V. last posted its earnings results on Thursday, December 26th, 2024. The company reported $-15.6 earnings per share for the quarter, missing analysts' consensus estimates of $-4.4 by $11.2. The company had revenue of 214,761 for the quarter and had revenue of 895,479 for the year. Mainz Biomed B.V. has generated $-2 earnings per share over the last year ($-1.62 diluted earnings per share) and currently has a price-to-earnings ratio of -2.92. Mainz Biomed B.V. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 8th, 2025 based on prior year's report dates.
Mainz Biomed B.V. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/08/2024 | Q4 2023 | -$0.32 | -$0.24 | 0.08 | $253,332 | $214,761 |
| 06/30/2023 | Q2 2023 | N/A | -$0.90 | N/A | $283,333 | $500,208 |
| 04/07/2023 | Q4 2022 | N/A | -$0.87 | N/A | $278,500 | $251,397 |
| 06/29/2022 | Q2 2022 | N/A | -$1.00 | N/A | N/A | $278,480 |
| 05/02/2022 | Q4 2021 | N/A | -$1.30 | N/A | N/A | $160,037 |
| 06/29/2021 | Q2 2021 | N/A | -$0.02 | N/A | N/A | $417,311 |
| 12/30/2020 | Q4 2020 | N/A | -$0.03 | N/A | N/A | $246,782 |
| 06/29/2020 | Q2 2020 | N/A | -$0.03 | N/A | N/A | $246,782 |
| 12/30/2019 | Q4 2019 | N/A | -$0.02 | N/A | N/A | $70,348 |
| 06/29/2019 | Q2 2019 | N/A | -$0.02 | N/A | N/A | $70,348 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Mainz Biomed B.V. Earnings: FAQ's
Mainz Biomed B.V. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 8th, 2025 based offlast year's report dates.
The conference call for Mainz Biomed B.V.'s latest earnings report can be listened to online.
The conference call transcript for Mainz Biomed B.V.'s latest earnings report can be read online.
Mainz Biomed B.V. (:MYNZ) has a recorded annual revenue of $895,479.
Mainz Biomed B.V. (:MYNZ) has a recorded net income of $-26,295,727.Mainz Biomed B.V. has generated $-1.62 earnings per share over the last four quarters.
Mainz Biomed B.V. (:MYNZ) has a price-to-earnings ratio of -2.92 and price/earnings-to-growth ratio is -0.08.